Cell type analysis of lymphocyte infiltration and cytokine profiles in breast cancer development and progression
- Prosjektnummer
- 2016065
- Ansvarlig person
- Vessela N. Kristensen
- Institusjon
- Akershus universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 1. Underpinning
nei
NEI
NEI
nei
Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer.
Breast Cancer Res Treat 2020 Oct;183(3):585-598. Epub 2020 jul 24
PMID: 32710281
Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
Cancer Rep (Hoboken) 2020 Jun;3(3):e1248. Epub 2020 mai 28
PMID: 32671987
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.
Int J Cancer 2020 Nov 01;147(9):2515-2525. Epub 2020 jun 18
PMID: 32488909
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers.
BMC Cancer 2020 May 05;20(1):377. Epub 2020 mai 5
PMID: 32370743
Modeling molecular development of breast cancer in canine mammary tumors.
Genome Res 2020 Dec 23. Epub 2020 des 23
PMID: 33361113
Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer.
Sci Rep 2020 11 02;10(1):18802. Epub 2020 nov 2
PMID: 33139755
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Oncoimmunology 2020 09 29;9(1):1824644. Epub 2020 sep 29
PMID: 33457104
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
Cell Rep 2019 Dec 24;29(13):4389-4406.e10.
PMID: 31875548
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Nat Commun 2019 Dec 03;10(1):5499. Epub 2019 des 3
PMID: 31796750
Subtype-specific transcriptional regulators in breast tumors subjected to genetic and epigenetic alterations.
Bioinformatics 2020 02 15;36(4):994-999.
PMID: 31529022
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors.
Future Oncol 2019 Nov;15(32):3675-3682. Epub 2019 sep 12
PMID: 31513453
MicroRNA Networks in Breast Cancer Cells.
Methods Mol Biol 2018;1711():55-81.
PMID: 29344885
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab.
Oncoimmunology 2018;7(11):e1457598. Epub 2018 aug 6
PMID: 30377556
Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.
Mol Oncol 2018 Sep;12(9):1540-1558. Epub 2018 aug 9
PMID: 29741811
Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue.
Oncoimmunology 2017;6(11):e1356142. Epub 2017 aug 10
PMID: 29147603
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.
Oncotarget 2017 Aug 22;8(34):57121-57133. Epub 2017 jul 7
PMID: 28915659
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.
Breast Cancer Res 2017 Nov 28;19(1):125. Epub 2017 nov 28
PMID: 29183390
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Breast Cancer Res 2017 Nov 14;19(1):120. Epub 2017 nov 14
PMID: 29137653
DNA methylation at enhancers identifies distinct breast cancer lineages.
Nat Commun 2017 Nov 09;8(1):1379. Epub 2017 nov 9
PMID: 29123100
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun 2017 Oct 31;8(1):1221. Epub 2017 okt 31
PMID: 29089486
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Sci Rep 2017 Jul 17;7(1):5568. Epub 2017 jul 17
PMID: 28717182
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Breast Cancer Res 2017 Mar 29;19(1):44. Epub 2017 mar 29
PMID: 28356166
The Antigenicity of the Tumor Cell - Context Matters.
N Engl J Med 2017 02 02;376(5):491-493.
PMID: 28146670
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
Oncoimmunology 2016;5(12):e1248015. Epub 2016 okt 24
PMID: 28123884
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
Genome Biol 2016 Dec 09;17(1):250. Epub 2016 des 9
PMID: 27931250
A systematic comparison of copy number alterations in four types of female cancer.
BMC Cancer 2016 Nov 22;16(1):913. Epub 2016 nov 22
PMID: 27876019
Tumour hypoxia causes DNA hypermethylation by reducing TET activity.
Nature 2016 Sep 01;537(7618):63-68. Epub 2016 aug 17
PMID: 27533040
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients.
Cancer Res 2016 Sep 15;76(18):5326-36. Epub 2016 jul 12
PMID: 27406829
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
Oncoimmunology, 2018
- Lilly Anne Torland Prosjektdeltaker
- Torben Luders Prosjektdeltaker
- Nazli Bahrami Doktorgradsstipendiat (annen finansiering)
- Torill Sauer Prosjektdeltaker
- Miriam Ragle Aure Prosjektdeltaker
- Jürgen Geisler Prosjektdeltaker
- Bjørn Naume Prosjektdeltaker
- Olav Engebråten Prosjektdeltaker
- Marianne Eikhom Nome Doktorgradsstipendiat (annen finansiering)
- Shakila Jabeen Doktorgradsstipendiat (annen finansiering)
- Xavier Tekpli Medveileder
- Andliena Tahiri Postdoktorstipendiat (finansiert av denne bevilgning)
- David Quigley Prosjektdeltaker
- Vessela N. Kristensen Forskningsgruppeleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport